Improved Acromegaly Patient Satisfaction With Oral Octreotide Capsules Compared With Injectable Somatostatin Receptor Ligands in the MPOWERED Trial

Background: Improved patient-reported outcomes (PROs) are increasingly becoming a key treatment objective in acromegaly. Validated PROs were used to assess disease and treatment burden in the MPOWERED phase 3 trial in acromegaly, which also assessed safety and efficacy of oral octreotide capsules (O...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Murray B, Fleseriu, Maria, Dreval, Akexander V, Pokramovich, Yulia, Bondar, Irina, Isaeva, Elena, Molitch, Mark E, Macut, Djuro P, Leonova, Nina, Raverot, Gerald, Kirschner, Lawrence S, Chanson, Philippe, Gilgun-Sherki, Yossi, Ludlam, William H, Patou, Gary, Haviv, Asi, Biermasz, Nienke, Melmed, Shlomo, Strasburger, Christian J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090598/
http://dx.doi.org/10.1210/jendso/bvab048.1062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090598/
http://dx.doi.org/10.1210/jendso/bvab048.1062

Ejemplares similares